These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9518559)

  • 21. Tissue distribution and cellular localization of the levocabastine-sensitive neurotensin receptor mRNA in adult rat brain.
    Walker N; Lepee-Lorgeoux I; Fournier J; Betancur C; Rostene W; Ferrara P; Caput D
    Brain Res Mol Brain Res; 1998 Jun; 57(2):193-200. PubMed ID: 9675417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antinociception induced by central administration of histamine in the formalin test in rats.
    Mojtahedin A; Tamaddonfard E; Zanboori A
    Indian J Physiol Pharmacol; 2008; 52(3):249-54. PubMed ID: 19552055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of central cholinergic muscarinic receptors and histamine H1 receptors in hyperglycemia induced by prostaglandin F2 alpha in rats.
    Nonogaki K; Iguchi A; Zhu LX; Kunoh Y; Tamagawa T; Sakamoto N
    Neuroendocrinology; 1993 Jan; 57(1):146-51. PubMed ID: 8097574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of H1-antagonists on spatial memory deficit evaluated by 8-arm radial maze in rats.
    Chen Z; Chen JQ; Kamei C
    Acta Pharmacol Sin; 2001 Jul; 22(7):609-13. PubMed ID: 11749824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes.
    Dubuc I; Costentin J; Terranova JP; Barnouin MC; Soubrié P; Le Fur G; Rostène W; Kitabgi P
    Br J Pharmacol; 1994 Jun; 112(2):352-4. PubMed ID: 8075852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
    Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
    Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo investigations of neurotensin receptors in adipocytes, hepatocytes and enterocytes of rat.
    Piątek J; Maćkowiak P; Krauss H; Nowak D; Bogdański P
    Ann Agric Environ Med; 2011; 18(2):433-6. PubMed ID: 22216825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible neuronal mechanisms involved in neurotensin-induced catalepsy in mice.
    Shibata K; Yamada K; Furukawa T
    Psychopharmacology (Berl); 1987; 91(3):288-92. PubMed ID: 2882538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotensin-induced antinociception in mice: antagonism by thyrotropin-releasing hormone.
    Osbahr AJ; Nemeroff CB; Luttinger D; Mason GA; Prange AJ
    J Pharmacol Exp Ther; 1981 Jun; 217(3):645-51. PubMed ID: 6112261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid-induced release of neurotensin in the periaqueductal gray matter of freely moving rats.
    Stiller CO; Gustafsson H; Fried K; Brodin E
    Brain Res; 1997 Nov; 774(1-2):149-58. PubMed ID: 9452203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No development of tolerance to analgesia by repeated administration of H1 antagonists.
    Ghelardini C; Galeotti N; Bartolini A
    Life Sci; 1998; 63(22):PL 317-22. PubMed ID: 9839549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The low affinity neurotensin receptor antagonist levocabastine impairs brain nitric oxide synthesis and mitochondrial function by independent mechanisms.
    Lores-Arnaiz S; Karadayian AG; Gutnisky A; Rodríguez de Lores Arnaiz G
    J Neurochem; 2017 Dec; 143(6):684-696. PubMed ID: 28975622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
    de Graaf-in 't Veld T; Garrelds IM; van Toorenenbergen AW; Mulder PG; Gerth van Wijk R; Boegheim JP
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and autoradiographic localization of neurotensin binding sites in human sigmoid colon.
    Azriel Y; Burcher E
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1074-81. PubMed ID: 11356931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Slow wave sleep-inducing effects of first generation H1-antagonists.
    Saitou K; Kaneko Y; Sugimoto Y; Chen Z; Kamei C
    Biol Pharm Bull; 1999 Oct; 22(10):1079-82. PubMed ID: 10549859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of neurotensin-stimulated phosphoinositide hydrolysis in brain regions of long sleep and short sleep mice.
    Erwin VG; Radcliffe RA
    Brain Res; 1993 Nov; 629(1):59-66. PubMed ID: 7904533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of vasopressin on histamine H(1) receptor antagonist-induced spatial memory deficits in rats.
    Taga C; Sugimoto Y; Nishiga M; Fujii Y; Kamei C
    Eur J Pharmacol; 2001 Jul; 423(2-3):167-70. PubMed ID: 11448481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in synaptic proteins of the complex PSD-95/NMDA receptor/nNOS and mitochondrial dysfunction after levocabastine treatment.
    Lores-Arnaiz S; Karadayian AG; Gutnisky A; Miranda J; Rodríguez de Lores Arnaiz G
    Neurochem Int; 2021 Sep; 148():105100. PubMed ID: 34139299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EFFECTS OF HISTAMINE AND RELATED COMPOUNDS ON THE BOVINE IRIS DILATOR.
    KAMEI CH
    Methods Find Exp Clin Pharmacol; 1996 May; 18(4):273-8. PubMed ID: 8803959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2.
    Richard F; Barroso S; Martinez J; Labbé-Jullié C; Kitabgi P
    Mol Pharmacol; 2001 Dec; 60(6):1392-8. PubMed ID: 11723247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.